Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Rationally designed multitarget agents against inflammation and pain.

Authors: Hwang, S H; Wecksler, A T; Wagner, K; Hammock, B D

Published In Curr Med Chem, (2013)

Abstract: Arachidonic acid (ARA) undergoes enzyme-mediated oxidative metabolism, resulting in the formation of a number of biologically active metabolites. For over a century, these biochemical transformations have been the target of numerous pharmacological drugs for inflammation and pain. In particular, non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) selective inhibitors (coxibs) are widely used in the treatment of inflammation and pain. However, gastrointestinal (GI) and cardiovascular adverse effects of NSAIDs and coxibs, and recent findings demonstrating that there are significant risks from the disruption of oxylipin levels when pharmacologically inhibiting a single ARA cascade metabolic pathway, have led to studies involving the simultaneous inhibition of multiple pathways in ARA cascade. These studies suggest that multitarget inhibition represents a new and valuable option to enhance efficacy or reduce side-effects in the treatment of inflammation and pain. This review focuses on the crosstalk within the three pathways of the ARA cascade (cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP450)), and summarizes the current and future approaches of multitarget inhibitors for the treatment of eicosanoid driven inflammation and pain.

PubMed ID: 23410172 Exiting the NIEHS site

MeSH Terms: Animals; Arachidonic Acid/metabolism; Cyclooxygenase Inhibitors/chemistry; Cyclooxygenase Inhibitors/pharmacology*; Cytochrome P-450 Enzyme Inhibitors*; Cytochrome P-450 Enzyme System/metabolism; Drug Design*; Humans; Inflammation/drug therapy*; Inflammation/enzymology; Inflammation/metabolism; Lipoxygenase Inhibitors/chemistry; Lipoxygenase Inhibitors/pharmacology*; Lipoxygenase/metabolism; Molecular Targeted Therapy/methods; Pain/drug therapy*; Pain/enzymology; Pain/metabolism; Prostaglandin-Endoperoxide Synthases/metabolism; Signal Transduction/drug effects*

Back
to Top